Summary List PlacementSolo venture capitalist Zal Bilimoria has raised a new fund, and he hasn't even fully spent his previous one, he tells Insider. Bilimoria is the sole partner at Refactor Capital and has now closed $50 million for his third fund, Insider has learned. The new fund will be used to place bigger bets on seed-stage companies in biotech and healthcare, as companies in those areas raise huge rounds of funding often from hedge funds and multi-stage firms at soaring valuations. "There's just a flood of capital, and it's caused an inflation of round size at every single stage.
In this article
No tags related to this article.